Innocan Pharma Corp
F:IP40
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innocan Pharma Corp
F:IP40
|
IL |
|
S
|
SEMAPA Sociedade de Investimento e Gestao SGPS SA
ELI:SEM
|
PT |
|
W
|
Window Asia PCL
SET:WINDOW
|
TH |
|
S
|
Singha Estate PCL
SET:S
|
TH |
|
I
|
Italian Thai Development PCL
SET:ITD
|
TH |
|
Strongpoint ASA
OSE:STRO
|
NO |
|
S
|
Sri Trang Agro-industry PCL
SET:STA
|
TH |
|
F
|
Far East Fame Line DDB PCL
SET:FE
|
TH |
|
P
|
Peer for You PCL
SET:PEER
|
TH |
|
M
|
Mud & Hound PCL
SET:MUD
|
TH |
Intrinsic Value
Is IP40 undervalued or overvalued?
See the intrinsic value estimate for Innocan Pharma Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
IP40 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with IP40’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Innocan Pharma Does
Innocan Pharma Corp develops drug products based on cannabinoids, the active compounds from cannabis plants, with a focus on long-acting therapies for pain relief and other medical uses. The company is trying to turn cannabis-derived ingredients into regulated pharmaceutical products rather than consumer hemp or recreational items.
- Headquarters
- Israel IL
- Employees
- 8
- IPO date
- Sep 24, 2019
Earnings Waterfall
Innocan Pharma Corp
The intrinsic value for Innocan Pharma Corp (IP40) under the Base Case is hidden EUR.
Compared with the current market price of 1.17 EUR, the stock appears hidden.